Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L35 pseudogene 9 (RPL35P9) is a human processed pseudogene related to the ribosomal protein L35 (RPL35) gene. Processed pseudogenes typically arise from the retrotransposition of mRNA and lack regulatory elements needed for expression, so they do not produce functional proteins. RPL35P9 is one of multiple such L35-related pseudogenes scattered across the human genome. Unlike the canonical RPL35, which encodes a ribosomal protein involved in protein synthesis, RPL35P9 is not believed to have functional biological activity and is not considered a therapeutic target. There are no known drugs, disease associations, or biomarker uses related to RPL35P9. If you are seeking information about the functional, canonical target, refer instead to ribosomal protein L35 (RPL35), which is a bona fide ribosomal protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L35 pseudogene 9 (RPL35P9).